申请人:Ando Koji
公开号:US20100087480A1
公开(公告)日:2010-04-08
This invention provides a compound of the formula (I). These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. This invention also provides a pharmaceutical composition comprising the above compound.
这项发明提供了一种化合物,其化学式为(I)。这些化合物对于治疗由VR1受体过度激活引起的疾病症状,如哺乳动物中的疼痛等,具有益处。该发明还提供了一种包含上述化合物的药物组合物。